Aim: To investigate the clinical long-term outcomes 13 years following guided tissue regeneration (GTR) in deep intra-bony defects with and without additional application of autogenous platelet concentrate (APC).
2000) and is determined by the presence, amount and balance of growth factors crucial for periodontal wound healing, such as plateletderived growth factor (PDGF) or transforming growth factor-β (TGF-β) (Smith, Martínez, Cáceres, & Martínez, 2015) .
Autogenous platelet concentrate (APC), often also referred to as platelet-rich plasma (PRP) (Marx, 2001) , had been suggested as a natural, patient-own source of these relevant growth factors, as the α-granules of thrombocytes contain PDGF, TGF-β and insulin-like growth factor (Bosshardt, Stadlinger, & Terheyden, 2015; Smith et al., 2015) . APC had first been introduced in the field of oral and maxillofacial surgery in 1997 by Whitman et al. (Whitman, Berry, & Green, 1997) , while Marx et al. had been the first to propose the use of PRP for the modulation of bone healing (Marx et al., 1998) . Since then, several clinical studies have been published investigating the benefits of additional application of APC in regenerative periodontal therapy in combination either with GTR (Camargo et al., 2002; Cetinkaya, Keles, Pamuk, Balli, & Keles, 2014) , grafts (Demir, Şengün, & Berberoğlu, 2007; Hanna, Trejo, & Weltman, 2004; Okuda et al., 2005; Yassibag-Berkman, Tuncer, Subasioglu, & Kantarci, 2007) or combined GTR/graft therapy (Camargo et al., 2005 (Camargo et al., , 2009 Christgau, Moder, Wagner, et al., 2006; Döri et al., 2007a Döri et al., ,b, 2008 Moder, Taubenhansl, Hiller, Schmalz, & Christgau, 2012) .
In a prospective clinical split-mouth study from our group, the impact of additional application of APC on combined GTR/graft therapy with β-tricalcium phosphate (β-TCP) granules and a bio-resorbable, polylactic/polyglycolic acid copolymer (PLA/PGA) GTR membrane was investigated in deep intra-bony defects (Christgau, Moder, Wagner, et al., 2006) . Apart from a tendency to less membrane exposures and an initially accelerated bone density gain during the first 6 months, no relevant effects on the early regeneration outcomes were found after 6 and 12 months (Christgau, Moder, Wagner, et al., 2006) . In contrast, after 7 years, clinical results suggested even a possibly negative influence of APC showing less long-term stability of the clinical healing outcomes in test sites compared to the control sites without the additional application of APC (Moder et al., 2012) . To the best of our knowledge, there has been no study so far investigating the long-term results of more than 7 years following combined GTR/graft therapy with additional application of APC. Furthermore, Wu et al. recently concluded in their systematic review on the long-term efficacy of periodontal regenerative therapy that there is still an urgent need for more long-term data (Wu, Lin, Song, Su, & Tu, 2017) .
Consequently, the aim of this follow-up study was to evaluate the long-term outcomes 13 years after combined GTR/graft therapy with and without additional application of APC.
| MATERIALS AND METHODS

| Study design
This study is a 13-year follow-up of a controlled randomized prospective clinical split-mouth study investigating the influence of additional application of autogenous platelet concentrate (APC) on the healing results in deep intra-bony periodontal defects following guided tissue regeneration (GTR) combined with β-TCP (Christgau, Moder, Wagner, et al., 2006) . The study design followed the requirements outlined in the CONSORT 2010 statement (Moher et al., 2010) and was approved by the ethics committee of the University of Regensburg in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. After detailed description of the proposed treatments, written informed consent was obtained from all individual participants included in the study.
| Patient selection
The study originally included 25 systemically healthy patients recruited from the patient pool of the Department of Conservative Dentistry and Periodontology of the University Medical Center Regensburg. For inclusion in this study, all patients had to have one pair of contralateral deep intra-bony, interproximal periodontal defects with a probing pocket depth (PPD) of at least 6 mm and radiographic evidence of angular bone loss of at least 4 mm at baseline. None of the teeth showed furcation involvement. Full-mouth supra-and subgingival scaling and root planing as well as splinting of highly mobile teeth had to be successfully completed at least 4 to 6 weeks before surgery.
None of the patients suffered from a systemic disease with a possibly negative influence on healing outcomes.
| Clinical therapeutic procedures
The APC was prepared as described earlier in detail Christgau, Moder, Wagner, et al., 2006) . In brief, APCs were prepared at the Department of Transfusion Medicine of the University Medical Center Regensburg using an apheresis technique. For clinical application, 2.5 ml APC was reactivated with 0.5 ml of a sterile 10% calcium chloride solution. All surgical interventions were performed by one experienced surgeon (MC) according to the principles of GTR therapy and have been described in detail earlier (Christgau, Moder, Wagner, et al., 2006) . Allocation of treatment sites
Clinical relevance
Scientific rationale for the study: To investigate the long-term outcomes 13 years after combined GTR/graft therapy with additional application of autogenous platelet concentrate (APC) in deep intra-bony defects.
Principal findings: After 13 years, more than 80% of teeth were still in situ. Significant CAL gains were found after 1 and 13 years as compared to baseline irrespective of additional APC application. However, a new attachment loss of 1 mm occurred between 1 and 13 years.
Practical implications:
The clinical parameters after GTR/ graft therapy can be maintained over a period of 13 years, while additional application of APC showed no additional benefit.
to test and control groups was performed by means of a computergenerated randomization table created by a mathematician (KAH).
Both defects in each patient were treated in the same session.
Following sulcular incisions, buccal and oral muco-periosteal flaps were elevated. After debriding the defects thoroughly, test sites were treated as follows: root surfaces were conditioned with 24% EDTA gel (Prefgel; Straumann, Basel, Switzerland) for 2 min. After rinsing with sterile 0.9% sodium chloride solution, reactivated APC Christgau, Moder, Wagner, et al., 2006 ) was applied to the root surfaces. Subsequently, the defects were filled with β-TCP granules (Ceros; Mathys, Bettlach, Switzerland), which had been soaked in APC, and covered with a bio-resorbable PLA/PGA membrane (Resolut XT; Gore Medical, Flagstaff, AZ, USA). The surgical sites were closed tension-free by coronally repositioned flaps. Control sites were treated accordingly without applying APC, whereby the β-TCP granules had been soaked with patient blood taken from the surgical site. Postoperative procedures were as described earlier (Christgau, Moder, Wagner, et al., 2006) . After that period, further participation in the SPT programme was highly recommended, but most of the patients returned to their referring dentists. The remaining patients were scheduled twice a year for SPT in the undergraduate programme of the Department of Conservative Dentistry and Periodontology.
| Clinical examination
Clinical examination was performed by two blinded examiners (FC; LT), who had been calibrated to the principal investigator (MC) in advance. The examiners were not involved in the treatments and not aware of the treatment modality used in the individual defects.
The clinical parameters were recorded immediately before as well as 1 and 13 years after periodontal surgery. Oral hygiene was measured by means of the full-mouth approximal plaque index (API) (Lange, Plagmann, Eenboom, & Promesberger, 1977) and gingival inflammation by means of the papillary bleeding index (PBI) (Saxer & Mühlemann, 1975) .
The subsequent clinical parameters were recorded for assessment of the healing results following regenerative therapy using a pressure- 
| Compliance
For evaluation of the patients' compliance, the regularity of participation in supportive periodontal therapy (SPT) was calculated based on the dental chart of each individual patient. A patient who attended SPT at the Department of Conservative Dentistry and Periodontology of the University Medical Center Regensburg at least once per year was classified to have "regular SPT." Patients who failed no more than one year during the whole 13-year period were considered to have "irregular SPT." Patients failing more often were classified to have "no SPT" at the University Medical Center.
| Data analysis
The single patient was regarded to be the statistical unit in this study.
As discussed earlier (Christgau, Schmalz, Wenzel, & Hiller, 1997) , clinical measurements were reported as median values (with 25%/75% percentiles) and were statistically evaluated using a non-parametric procedure. Considering the paired nature of the split-mouth data, the Wilcoxon Signed-rank test was applied on a significance level of α = 0.05 using SPSS for Windows, version 23 (SPSS Inc., Chicago, IL, USA) (Woolson & Clarke, 2002) .
| RESULTS
All initially recruited 25 patients received the intended treatment and completed the 1-year observation period (baseline to 12 months) (Christgau, Moder, Wagner, et al., 2006) . After 13 years, three patients were not available anymore. Twenty-one of the remaining 22 patients could be scheduled for clinical examination, while the other patient was only available for an oral interview via telephone. 
| Compliance with SPT
The calculation of the SPT frequencies was carried out based on the dental charts of the 22 patients who were available for tooth survival analysis; 23% of the patients had participated regularly in SPT, 18% had participated irregularly and 59% received no SPT at the University Medical Center.
| Tooth survival analysis
Tooth survival was analysed in 22 patients. After 13 years, seven teeth in six patients had been extracted by the referring dentists due to prosthodontic reasons: four teeth in the test group and three teeth in the control group. Accordingly, 81.8% and 86.4% of the teeth were still in situ in the test or control group, respectively. No association of tooth loss could be found with regard to tooth type while there was a tendency for more tooth loss in initially deeper defects (six of seven tooth losses occurred in teeth with CAL of 12.0 mm or more at baseline; Table 1 ). Furthermore, poor compliance with the participation in SPT seemed to have an impact on tooth loss as well: it occurred in three patients with no SPT, in two patients with irregular SPT and only in one patient with regular SPT at the University Medical Center.
| Clinical parameters
For split-mouth analysis, the clinical data of 15 patients were available. The median full-mouth API increased from 10% at baseline to 12% after 1 year and 25% after 13 years, while the median full-mouth PBI declined from 14% at baseline to 10% after 1 year and 4% after 13 years. These differences were not statistically significantly different. The median PBI at the surgical sites was 1.0 at baseline in both, test and control sites, decreased to 0.0 after 1 year and remained F I G U R E 1 Flow chart of the study outline F I G U R E 2 Radiographic healing in a control site at baseline as well as 1 and 13 years after combined GTR/graft treatment without additional application of APC stable after 13 years. The median BOP was positive (bleeding) in both groups at baseline, negative (no bleeding) after 1 year and positive again after 13 years.
Both groups showed a median baseline PPD of 10.0 mm, which decreased by 6.0 mm (both groups) to 3.0 mm (test) or 4.0 mm (control), respectively, after 1 year. After 13 years, median PPD increased again by 1.0 mm to 5.0 mm (both groups). The median REC started at baseline at 1.0 mm (test) or 2.0 mm (control) and increased to 3.0 mm (both) after 1 year, declining again in test group to 2.0 mm while remaining stable in the control group after 13 years. The median CAL at baseline was found to be 10.0 mm in test sites and 12.0 mm in control sites and improved by 5.0 mm to 6.0 mm in both groups after 1 year.
After 13 years, the median CAL increased again by 1.0 mm to 7.0 mm in both groups. The vertical relative attachment gain after 1 year was found to be 75% in the test and 76.9% in the control group and decreased to 50% in the test and 66.7% in the control group after 13 years. No significant differences between test and control sites were found. The results of the clinical examination are summarized in Tables 2 and 3 . Additionally, Table 4 shows the frequency distribution of sites with PPD ≤3 mm, 4-5 mm as well as ≥6 mm for all test and control sites at baseline as well as after 1 and 13 years.
| DISCUSSION
The present study investigated the long-term healing outcomes 13 years after combined GTR/graft therapy with or without additional application of autogenous platelet concentrate. In general, studies reporting on long-term outcomes after regenerative periodontal therapies are scarce (Wu et al., 2017) Statistically significant difference between test and control (p ≤ .05): not applicable for this data.
than in the present study (Cortellini, Buti, Pini Prato, & Tonetti, 2017) .
Furthermore, this is the first study investigating the impact of APC on the long-term clinical healing outcomes after combined GTR/graft therapy.
| Clinical parameters
A general drawback of this kind of long-term studies is the fact that usually only a part of the initial patient population is still available.
Accordingly, in the present study, only 15 patients were still available for split-mouth analysis after 13 years, while in the original study, 25 patients had been included, contributing test and control defects for split-mouth analysis each. Therefore, a reduced statistical power of the long-term data must be accepted and, consequently, the results have to be interpreted with caution. While in the original study on 25 patients, test and control defects both showed a median baseline CAL of 10.0 mm (Christgau, Moder, Wagner, et al., 2006) ; in this 13-year follow-up, the baseline CAL was 10.0 mm in test and 12.0 mm in control sites. This can be explained by the selection of the 15 patients, who were still available for split-mouth analysis after 13 years. However, this difference in baseline CAL was not statistically significant.
In the present study, the median CAL gain 1 year after periodontal surgery measured 5.0 mm in both groups. These results were in the upper range compared to those of previous studies on GTR therapy with bio-resorbable membranes in intra-bony defects (Murphy & Gunsolley, 2003) , where at best a mean CAL gain of 4.60 mm was reported 1 year after GTR using PLA/PGA membranes (Cortellini, Pini Prato, & Tonetti, 1996) . The better outcomes in our study may be explained by the combination with graft material.
Studies reporting on long-term results after GTR or combined GTR/graft therapy with bio-resorbable membranes in intra-bony defects found mean CAL gains in a range between 2.4 and 3.8 mm 10 years postoperatively (Nickles et al., 2009; Nygaard-Østby et al., 2010; Pretzl et al., 2008 Pretzl et al., , 2009 Sculean, Kiss, et al., 2008) . Statistically significant difference between test and control (p ≤ .05): not applicable for this data. n: Number of split-mouth defects.
T A B L E 4 Split-mouth analysis:
Frequency distribution of PPD ≤ 3 mm, 4-5 mm as well as ≥6 mm at the surgical sites at baseline as well as after 1 and 13 years different. Although these CAL gains are similar or slightly better as compared to the aforementioned long-term studies, we observed a new median CAL loss of 1.0 mm in both groups between the 1-year and the 13-year follow-up. This is also reflected in the frequency distribution of sites with PPD ≤ 3 mm, 4-5 mm as well as ≥6 mm at the three examination time points: while after 1 year, all sites showed PPD of maximum 5 mm, after 13 years, some sites worsened again (seven and four sites with PPD ≥ 6 mm for test and control group, respectively). These results are in line with the literature, where CAL changes ranged from a mean CAL loss of 1.62 mm between 1 and 10 years postoperatively (Pretzl et al., 2009 ) to a mean CAL gain of 1.2 mm between 9 months and 10 years after surgery (NygaardØstby et al., 2010) . This additional CAL gain in the latter study was explained by a still not complete tissue maturation after 9 months respectively) between 1 and 20 years after GTR therapy using expanded polytetrafluoroethylene (ePTFE) membranes (Cortellini et al., 2017) .
| Tooth loss and compliance
Hujoel et al. suggested to use true end points (e.g. tooth loss) in addition to surrogate parameters (e.g. CAL changes) for evaluation of distinct periodontal treatment approaches (Hujoel, Armitage, & García, 2000) . In this clinical trial, 13 years after periodontal surgery, 81.8%
and 86.4% of the teeth were still in situ in the test or control group, respectively. Consequently, seven teeth (test: 4; control: 3) in six patients were lost during the study period. However, the decisions for tooth retention or extraction were made alio loco by the respective referring dentists. According to the patients' self-report, the tooth extractions were due to prosthodontic reasons (mostly in the context of more complex prosthetic rehabilitations) and thus may not be considered as periodontal complications.
It is well-known that regular participation in supportive periodontal therapy (SPT) is crucial for long-term success of periodontal treatment (Axelsson & Lindhe, 1978; Axelsson, Nyström, & Lindhe, 2004 ).
Cortellini & Tonetti found significantly more new attachment loss and tooth loss in cases without regular SPT in a cumulative long-term analysis up to 16 years following GTR (Cortellini & Tonetti, 2004) .
In the present study, all patients had to attend SPT every 3 months during the first year postoperatively. However, during the following 12 years, only 23% of the patients further participated in the SPT programme at the University Medical Center on a regular basis (i.e.
at least once per year) and 18% received SPT irregularly (i.e. maximum one year without SPT during the entire study period). In contrast, 59% of the patients did not further attend SPT at the University Medical Center during this period (i.e. two or more years without attendance). This may be reflected in the tooth survival analysis, where five of the six patients with tooth loss showed no or irregular SPT attendance at the University Medical Center. However, due to the geographical context and the wide catchment area of the University Medical Center Regensburg, many patients had to accept long ways accompanied by additional costs to reach the University Medical
Center and most of them preferred to attend their local dentists after the 1-year follow-up. Return of the patients to their referring dentists does not necessarily mean insufficient professional maintenance.
However, the quality of the maintenance could not be controlled by the investigators. Having this in mind, it is noteworthy that the oral hygiene parameters remained quite stable over the 13-year period with a slightly increasing full-mouth API (10% at baseline, 12% after 1 year and 25% after 13 years) and even marginally decreasing fullmouth PBI (14% at baseline, 10% after 1 year and 4% after 13 years).
Furthermore, it has to be emphasized that both, test and control sites, suffered equally from the low participation in SPT at the University Medical Center because due to the split-mouth design, every patient served as his or her own control (Hujoel & Moulton, 1988; Koch & Paquette, 1997) .
| Impact of additional application of APC
As the aim of the original split-mouth study was to investigate the effects of APC on clinical healing outcomes after combined GTR/ graft therapy, all influence factors were kept constant besides the additional application of APC. Therefore, a negative control group (i.e. access flap surgery) had not been included in this split-mouth study.
In the present study, no benefits of additional application of APC were found on long-term clinical healing outcomes following combined GTR/graft therapy. However, these results should be interpreted with caution as only 15 of the original 25 were still available for split-mouth analysis after 13 years, wherefore a reduced statistical power must be accepted. Nevertheless, the results of this study are in accordance with some recent systematic reviews concluding that platelet concentrates may reveal a positive adjunctive effect on periodontal regenerative therapy outcomes in intra-bony defects when combined with graft materials alone, but not in combination with GTR or combined GTR/graft therapy (Del Fabbro, Bortolin, Taschieri, & Weinstein, 2011; Hou, Yuan, Aisaiti, Liu, & Zhao, 2016; Panda, Doraiswamy, Malaiappan, Varghese, & Del Fabbro, 2016; Roselló-Camps et al., 2015) . It was suggested that the proven efficacy of GTR could mask additional effects of platelet concentrates. When using graft materials without membranes, the dense fibrin network formed after platelet activation may act as a barrier and prevent epithelial migration into the defect, explaining the superior results in these cases (Del Fabbro et al., 2011; Panda et al., 2016) .
In the 7-year follow-up of our study, it was found that the test sites exhibited worse clinical healing outcomes than the control sites in terms of a statistically significant greater increase in PPD and CAL loss from 1 to 7 years (Moder et al., 2012) . After 13 years, we still found less median CAL gain between baseline and 13 years for test (3.0 mm) than control sites (5.0 mm), which was however not found to be statistically significant anymore. Likewise, the frequency distribution of sites with PPD ≤ 3 mm, 4-5 mm as well as ≥6 mm showed slightly more worsening of test sites after 13 years as compared to control sites. Although the baseline characteristics of test and control defects exhibited no statistically significant differences, there was a tendency for worse median CAL at baseline in control (12.0 mm) than in test defects (10.0 mm). This may explain the trend for better performance of control than test defects because it is well-known that defects with greater defect depth at baseline may have a better potential for periodontal regeneration than more shallow defects (Kornman & Robertson, 2000) .
| CONCLUSIONS
Most of the CAL gain found 1 year after combined GTR/graft therapy could be maintained over a period of 13 years, although there was some new CAL loss between 1 and 13 years.
Within the limitations of this 13-year study, the application of APC showed no statistically significant benefits on the long-term clinical healing outcomes. This is in line with the 1-year results of the original study.
